Skip to content

Clinical trials

Hematologic Neoplasms trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Country / region: Hungary Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20091
20111
20121
20171
20181
20214
20222
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting6
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Novartis Pharmaceuticals2
Amgen1
Bristol-Myers Squibb1
Del-Pest Central Hospital - National Institute of Hematology and Infectious Diseases1
European Society for Blood and Marrow Transplantation1
Gamida Cell -Teva Joint Venture Ltd.1
Incyte Corporation1
Kura Oncology, Inc.1
Menarini Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms15
Leukemia3
Lymphoma, Non-Hodgkin3
Bone Marrow Diseases2
Hematologic Diseases2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Leukemia, Myeloid, Acute2
Lymphoma, Large B-Cell, Diffuse2
Blood Protein Disorders1
Bone Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.